Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Return on Sales (2016 - 2020)

Historic Return on Sales for KalVista Pharmaceuticals (KALV) over the last 8 years, with Q1 2021 value amounting to 2.25%.

  • KalVista Pharmaceuticals' Return on Sales rose 55900.0% to 2.25% in Q1 2021 from the same period last year, while for Jan 2021 it was 2.25%, marking a year-over-year increase of 12300.0%. This contributed to the annual value of 31.71% for FY2025, which is 342400.0% up from last year.
  • KalVista Pharmaceuticals' Return on Sales amounted to 2.25% in Q1 2021, which was up 55900.0% from 3.88% recorded in Q4 2020.
  • KalVista Pharmaceuticals' Return on Sales' 5-year high stood at 0.6% during Q2 2018, with a 5-year trough of 56.78% in Q3 2017.
  • Its 5-year average for Return on Sales is 10.24%, with a median of 2.66% in 2019.
  • In the last 5 years, KalVista Pharmaceuticals' Return on Sales crashed by -515400bps in 2017 and then surged by 549200bps in 2018.
  • Quarter analysis of 5 years shows KalVista Pharmaceuticals' Return on Sales stood at 5.27% in 2017, then surged by 84bps to 0.84% in 2018, then tumbled by -167bps to 2.24% in 2019, then plummeted by -73bps to 3.88% in 2020, then soared by 42bps to 2.25% in 2021.
  • Its last three reported values are 2.25% in Q1 2021, 3.88% for Q4 2020, and 3.19% during Q3 2020.